Trigg Leslie (CIK 1304125) reported 19 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-19). Recent activity: Sell OM (3,445 shares), Sell EXAS (3,244 shares), Sell EXAS (13,925 shares), Sell OM (3,361 shares), Sell OM (11,794 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 3,445 | $12,746 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | Director | Sell | 3,244 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | Director | Sell | 13,925 | $0 |
| 2026-02-19 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 3,361 | $11,259 |
| 2026-01-21 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 11,794 | $60,385 |
| 2026-01-21 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 2,120 | $10,706 |
| 2026-01-08 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 1,795 | $7,665 |
| 2025-11-18 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 916 | $4,214 |
| 2025-08-18 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 904 | $11,644 |
| 2025-06-16 | EXACT SCIENCES CORP (EXAS) | Director | Buy | 7,670 | $0 |
| 2025-06-11 | Outset Medical, Inc. (OM) | Chair and CEO | Buy | 65,103 | $0 |
| 2025-05-16 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 935 | $16,643 |
| 2025-05-01 | EXACT SCIENCES CORP (EXAS) | Director | Buy | 8,527 | $0 |
| 2025-03-11 | Outset Medical, Inc. (OM) | Chair and CEO | Buy | 625,000 | $0 |
| 2025-02-19 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 14,611 | $0 |
| 2025-01-22 | Outset Medical, Inc. (OM) | Chair and CEO | Buy | 99,419 | $0 |
| 2025-01-22 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 4,403 | $0 |
| 2025-01-22 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 42,384 | $0 |
| 2025-01-22 | Outset Medical, Inc. (OM) | Chair and CEO | Sell | 18,449 | $0 |
Source: SEC Form 4 filings · as of 2026-05-19